The Inhaled Administration of KF19514, a Phosphodiesterase 4 and 1 Inhibitor, Prevents Antigen-induced Lung Inflammation in Guinea Pigs

By Manabe H.   Akuta K.   Kawasaki H.   Ohmori K.  

Pulmonary Pharmacology & Therapeutics, Vol. 13, Iss. 1, 2000-02 ,pp. : 5-11

Academic Press

Access to resources Recommend Favorite

Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis

By Francischi J.N.   Yokoro C.M.   Poole S.   Tafuri W.L.   Cunha F.Q.   Teixeira M.M.  

European Journal of Pharmacology, Vol. 399, Iss. 2, 2000-07 ,pp. : 243-249

Elsevier

Access to resources Recommend Favorite

The anti-inflammatory properties of the phosphodiesterase (PDE)-5 inhibitor, sildenafil, make it a potential therapy for asthma and COPD

By  

Inpharma, Vol. 1, Iss. 1425, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?

By Teixeira M.M.   Gristwood R.W.   Cooper N.   Hellewell P.G.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 5, 1997-05 ,pp. : 164-170

Elsevier

Access to resources Recommend Favorite

Antinociceptive and anti-inflammatory properties of an adenosine kinase inhibitor and an adenosine deaminase inhibitor

By Poon A.   Sawynok J.  

European Journal of Pharmacology, Vol. 384, Iss. 2, 1999-11 ,pp. : 123-138

Elsevier

Access to resources Recommend Favorite